Discover 1,825 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,825
Active & Responsive
CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting
for
Cardiac Valve Disease
Location: Durham NC, Greenville NC, Philadelphia PA, Cleveland OH,
Sponsor: Corcym S.r.l
Sex: All
Age: 0+
Code: NCT05002543
Recruiting
Active & Responsive
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
for
Liver Transplant
Location: Durham NC, Baltimore MD, Pittsburgh PA, Philadelphia PA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18+
Code: NCT06075745
Phase 2, Recruiting
Active & Responsive
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Location: Durham NC, Fairfax VA, Cleveland OH, Nashville TN,
Sponsor: Institut de Recherches Internationales Servier
Sex: All
Age: 18+
Code: NCT05786924
Phase 1, Phase 2, Recruiting
Active & Responsive
A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)
for
Cytomegalovirus Prophylaxis
Location: Durham NC, Charlotte NC, Atlanta GA, Pittsburgh PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT07199465
Phase 1, Recruiting
Active & Responsive
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: Durham NC, Charlotte NC, Richmond VA, Lexington KY,
Sponsor: Caribou Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05722418
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
HCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM
for
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06822972
Phase 2, Recruiting
Active & Responsive
HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
for
Hematologic Malignancy
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06731504
Early Phase 1, Recruiting
Active & Responsive
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
for
Ovarian Cancer, Fallopian Tube Cancer
Location: Durham NC, Philadelphia PA, New York NY, Chicago IL,